$NBIX SEC Filings

Filed On	Filing
15 Oct 2026	SCHEDULE 13G/A
07 Oct 2026	Form 3: Roberts Eiry, Chief Medical Officer Holds 51,331 shares of Common Stock
28 Sep 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers On September 28, 2026, the Board of Directors (the “Board”) of Neurocrine Biosciences, Inc. (the “Company”) appointed Eiry W. Roberts, M.D., to succeed Sanjay Keswani, M.D., as the Company’s Chief Medical Officer, effective September 28,...
15 Sep 2026	Form 4: Delaet Ingrid, Chief Regulatory Officer Received 4,483 shares as a grant or award · Gave up 2,419 shares to cover exercise price or tax ($378K)
15 Sep 2026	Form 4: Boyer David W., Chief Corp. Affairs Officer Received 3,587 shares as a grant or award · Gave up 1,936 shares to cover exercise price or tax ($302K) · Sold 826 shares ($130K)
15 Sep 2026	Form 4: Onyia Jude, Chief Scientific Officer Received 3,587 shares as a grant or award · Gave up 1,936 shares to cover exercise price or tax ($302K)
15 Sep 2026	Form 4: Keswani Sanjay Chandru, Chief Medical Officer Received 3,914 shares as a grant or award · Gave up 2,112 shares to cover exercise price or tax ($330K)
15 Sep 2026	Form 4: Cooke Julie, Chief Human Resources Officer Received 3,587 shares as a grant or award · Gave up 1,936 shares to cover exercise price or tax ($302K)
15 Sep 2026	Form 4: Abernethy Matt, Chief Financial Officer Received 5,020 shares as a grant or award · Gave up 2,709 shares to cover exercise price or tax ($423K) · Sold 2,311 shares ($363K)
15 Sep 2026	Form 4: Benevich Eric, Chief Commercial Officer Received 6,275 shares as a grant or award · Gave up 3,386 shares to cover exercise price or tax ($529K)
15 Sep 2026	Form 4: Gano Kyle, Director Received 8,117 shares as a grant or award · Gave up 4,380 shares to cover exercise price or tax ($684K)
15 Sep 2026	Form 4: Lippoldt Darin, Chief Legal Officer Received 4,483 shares as a grant or award · Gave up 2,419 shares to cover exercise price or tax ($378K)
15 Sep 2026	Form 4: Gorman Kevin Charles, Director Received 14,343 shares as a grant or award · Gave up 7,839 shares to cover exercise price or tax ($1.22M)
14 Sep 2026	144
14 Sep 2026	144
10 Sep 2026	Form 4: Benevich Eric, Chief Commercial Officer Received 3,194 shares by exercise or conversion ($138K) · Sold 2,154 shares ($333K)
09 Sep 2026	144
03 Sep 2026	Form 4: Sherwin Stephen A, Director Gave 1,000 shares as a gift
05 Aug 2026	Form 4: Onyia Jude, Chief Scientific Officer Gave 2,409 shares as a gift
31 Jul 2026	S-8

Comments